ANI Pharmaceuticals
ANIP
#5269
Rank
NZ$2.93 B
Marketcap
NZ$127.83
Share price
-1.59%
Change (1 day)
-19.21%
Change (1 year)

EPS for ANI Pharmaceuticals (ANIP)

EPS in 2026 (TTM): NZ$8.39

According to ANI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ$8.58. In 2025 the company made an earnings per share (EPS) of NZ$6.21 an increase over its 2024 EPS that were of NZ-$1.99.

EPS history for ANI Pharmaceuticals from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$8.3935.03%
2025NZ$6.21-412.5%
2024NZ-$1.99
2022NZ-$5.40-6.46%
2021NZ-$5.7772.87%
2020NZ-$3.34-476%
2019NZ$0.89-62.12%
2018NZ$2.34
2015NZ$2.38-47.66%
2014NZ$4.55-142.11%
2013NZ-$10.79

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$11.82 37.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.35-84.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
NZ$12.89 50.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
NZ$27.07 215.73%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Evoke Pharma
EVOK
NZ-$4.47-152.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$7.72-190.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$1.12-86.96%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Royalty Pharma
RPRX
NZ$3.33-61.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lannett Company
LCI
NZ-$44.88-623.40%๐Ÿ‡บ๐Ÿ‡ธ USA